Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Strata Critical Medical, Inc.SRTA · Entity 5512 | Director · Co-CEO and CFO | September 24, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Strata Critical Medical, Inc.
Report date September 24, 2026 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 1,757,850 |
Ending reported balance
After 2026-09-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-24 · Grant · Acquired 177,858 · Balance 1,856,206 F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29. 2025. Row 2 · 2026-09-24 · Tax withholding · Disposed 98,356 · Balance 1,757,850 F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29. 2025.
F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2024 Filed Jan 3, 2024 21:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 57,686 | $0.18 Strike: $0.18 | $10,383.48 |
DisclosureSEC source: 0001779128-24-000004 · wk-form4_1704315736.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Class A common stock, $0.0001 par value per share · 57,686 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 57,686 | $0.18 | $10,383.48 |
DisclosureSEC source: 0001779128-24-000004 · wk-form4_1704315736.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 15, 2023 23:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 6,793 | $3.22 | $21,863.95 |
DisclosureSEC source: 0001779128-23-000138 · wk-form4_1702684729.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,330,624 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 23:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 16,073 | $3.20 | $51,493.07 |
DisclosureSEC source: 0001779128-23-000138 · wk-form4_1702684729.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,337,417 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.12 to $3.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 23:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 14,508 | $2.95 | $42,773.94 |
DisclosureSEC source: 0001779128-23-000138 · wk-form4_1702684729.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,353,490 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $3.0750, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 06, 2023 Filed Oct 6, 2023 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 14,488 | $2.40 | $34,740.78 |
DisclosureSEC source: 0001779128-23-000110 · wk-form4_1696634755.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,367,998 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.335 to $2.435, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 11,220 | $2.41 | $27,063.76 |
DisclosureSEC source: 0001779128-23-000110 · wk-form4_1696634755.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,382,486 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.375 to $2.505, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 13,419 | $2.51 | $33,691.08 |
DisclosureSEC source: 0001779128-23-000110 · wk-form4_1696634755.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,393,706 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.495 to $2.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 14:39 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 33,712 | $0.18 Strike: $0.18 | $6,068.16 |
DisclosureSEC source: 0001779128-23-000070 · wf-form4_168977755288681.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 407,686 Underlying: Class A common stock, $0.0001 par value per share · 33,712 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 14:39 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 33,712 | $0.18 | $6,068.16 |
DisclosureSEC source: 0001779128-23-000070 · wf-form4_168977755288681.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,407,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2023 Filed Jul 10, 2023 22:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 32,774 | $3.88 | $127,307.33 |
DisclosureSEC source: 0001779128-23-000066 · wf-form4_168902932044553.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,373,413 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.81 to $3.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 07, 2023 Filed Jul 10, 2023 22:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 25,371 | $3.82 | $96,962.89 |
DisclosureSEC source: 0001779128-23-000066 · wf-form4_168902932044553.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,406,187 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 22:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 25,652 | $3.75 | $96,223.22 |
DisclosureSEC source: 0001779128-23-000066 · wf-form4_168902932044553.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,431,558 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.605 to $3.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 10, 2023 Filed Apr 11, 2023 21:10 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 19,159 | $2.83 | $54,287.03 |
DisclosureSEC source: 0001779128-23-000040 · wf-form4_168124739543748.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,457,210 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.805 to $2.935, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 21:10 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 9,727 | $2.92 | $28,357.12 |
DisclosureSEC source: 0001779128-23-000040 · wf-form4_168124739543748.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,476,369 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 05, 2023 Filed Apr 11, 2023 21:10 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 12,627 | $2.98 | $37,603.21 |
DisclosureSEC source: 0001779128-23-000040 · wf-form4_168124739543748.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,486,096 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.825 to $3.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 20:38 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 49,451 | $0.18 Strike: $0.18 | $8,901.18 |
DisclosureSEC source: 0001779128-23-000017 · wf-form4_167537030000142.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 49,451 shares Expires 2029-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 20:38 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 49,451 | $0.18 | $8,901.18 |
DisclosureSEC source: 0001779128-23-000017 · wf-form4_167537030000142.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,498,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2023 Filed Jan 12, 2023 15:31 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 4,306 | $3.47 | $14,959.04 |
DisclosureSEC source: 0001779128-23-000015 · wf-form4_167353746919119.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,449,272 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:28 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 56,238 | $0.18 Strike: $0.18 | $10,122.84 |
DisclosureSEC source: 0001779128-23-000001 · wf-form4_167297210648396.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,451 Underlying: Class A common stock, $0.0001 par value per share · 56,238 shares Expires 2029-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:28 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 56,238 | $0.18 | $10,122.84 |
DisclosureSEC source: 0001779128-23-000001 · wf-form4_167297210648396.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,453,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2022 Filed Nov 14, 2022 15:04 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 916,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-22-000122 · wf-form4_166843825828837.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397,340 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest on the first day of every calendar quarter following January 1, 2023 (with the first tranche to vest on April 1, 2023), with any remaining unvested RSUs to vest on January 1, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 14:17 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 3,744 | $3.97 | $14,865.93 |
DisclosureSEC source: 0001779128-22-000103 · wf-form4_166549781558335.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,017 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $3.9986, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 15, 2022 Filed Aug 8, 2022 14:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 3,677 | $4.41 | $16,215.57 |
DisclosureSEC source: 0001779128-22-000072 · wf-form4_165996878370944.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484,761 Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 14:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, par value $0.0001 per share | 3,866 | $8.60 | $33,247.60 |
DisclosureSEC source: 0001779128-22-000028 · wf-form4_164925569829924.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,438 Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 21:20 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 70,000 | $0.18 Strike: $0.18 | $12,600.00 |
DisclosureSEC source: 0001779128-22-000002 · wf-form4_164375038434093.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,689 Underlying: Class A common stock, par value $0.0001 per share · 70,000 shares Expires 2029-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 21:20 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, par value $0.0001 per share | 70,000 | $0.18 | $12,600.00 |
DisclosureSEC source: 0001779128-22-000002 · wf-form4_164375038434093.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 16:40 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, par value $0.0001 per share | 106,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-21-000021 · wf-form4_164001841480227.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,304 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest every three calendar months from January 1,2022 (with the first tranche to vest on April 1, 2022), with any remaining unvested Restricted Stock Units to vest on January 1, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 6,312 | $0.18 Strike: $0.18 | $1,136.16 |
DisclosureSEC source: 0001779128-21-000011 · wf-form4_163969718553035.xml · derivative · entry 5 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,377 Underlying: Class A common stock, par value $0.0001 per share · 6,312 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 13,688 | $0.18 Strike: $0.18 | $2,463.84 |
DisclosureSEC source: 0001779128-21-000011 · wf-form4_163969718553035.xml · derivative · entry 4 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, par value $0.0001 per share · 13,688 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, par value $0.0001 per share | 6,312 | $0.18 | $1,136.16 |
DisclosureSEC source: 0001779128-21-000011 · wf-form4_163969718553035.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, par value $0.0001 per share | 13,688 | $0.18 | $2,463.84 |
DisclosureSEC source: 0001779128-21-000011 · wf-form4_163969718553035.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 23:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 125,320 | $8.38 | $1,050,181.60 |
DisclosureSEC source: 0001779128-21-000011 · wf-form4_163969718553035.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,933 Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 21:05 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001062993-21-008792 · form4.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,688 Underlying: Class A common stock, par value $0.0001 per share · 5,000 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 21:05 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 5,000 | $0.18 | $900.00 |
DisclosureSEC source: 0001062993-21-008792 · form4.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 22:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001062993-21-007691 · form4.xml · derivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,689 Underlying: Class A common stock, par value $0.0001 per share · 75,000 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 22:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 75,000 | $0.18 | $13,500.00 |
DisclosureSEC source: 0001062993-21-007691 · form4.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 22:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 122,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-007691 · form4.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,253 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 66.67% of the RSUs will vest on July 1, 2023, and the remaining RSUs will vest on July 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.